{
  "trial_id": "NCT02462967",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), history of diabetes mellitus, history of obesity, baseline HVPG measurement, liver biopsy results (Ishak stage), presence of small varices, baseline serum alanine aminotransferase levels, baseline serum aspartate aminotransferase levels, baseline platelet count, baseline serum albumin levels, baseline international normalized ratio (INR), baseline direct bilirubin levels, baseline alpha fetoprotein levels, Model End-Stage Liver Disease (MELD) score, Child Turcotte Pugh class, estimated creatinine clearance, use of statins, use of angiotensin converting enzyme inhibitors, use of angiotensin II receptor blockers, use of \u03b21 selective adrenergic receptor inhibitors, alcohol consumption history, smoking status, baseline cardiovascular health status, baseline renal function, baseline pulmonary function, baseline psychiatric health status, baseline gastrointestinal health status, baseline systemic inflammatory status, baseline metabolic or endocrine disorder status, baseline infection status, history of malignancy, prior participation in investigational new drug studies, baseline medication use, baseline laboratory values, baseline imaging results for hepatocellular carcinoma.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Portal Pressure",
          "baseline HVPG measurement"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "history of diabetes mellitus",
        "history of obesity",
        "liver biopsy results (Ishak stage)",
        "presence of small varices",
        "baseline serum alanine aminotransferase levels",
        "baseline serum aspartate aminotransferase levels",
        "baseline platelet count",
        "baseline serum albumin levels",
        "baseline international normalized ratio (INR)",
        "baseline direct bilirubin levels",
        "baseline alpha fetoprotein levels",
        "Model End-Stage Liver Disease (MELD) score",
        "Child Turcotte Pugh class",
        "estimated creatinine clearance",
        "use of statins",
        "use of angiotensin converting enzyme inhibitors",
        "use of angiotensin II receptor blockers",
        "use of \u03b21 selective adrenergic receptor inhibitors",
        "alcohol consumption history",
        "smoking status",
        "baseline cardiovascular health status",
        "baseline renal function",
        "baseline pulmonary function",
        "baseline psychiatric health status",
        "baseline gastrointestinal health status",
        "baseline systemic inflammatory status",
        "baseline metabolic or endocrine disorder status",
        "baseline infection status",
        "history of malignancy",
        "prior participation in investigational new drug studies",
        "baseline medication use",
        "baseline laboratory values",
        "baseline imaging results for hepatocellular carcinoma"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HVPG measurement, Liver biopsy results, Platelet count, Serum alanine aminotransferase levels, Serum aspartate aminotransferase levels, Serum albumin, International normalized ratio (INR), Direct bilirubin, Alpha fetoprotein, Model End-Stage Liver Disease (MELD) score, Child Turcotte Pugh Class, Estimated creatinine clearance, History of hepatic decompensation, Presence of varices, History of liver disease, History of alcohol consumption, History of solid organ transplant, Use of nonselective \u03b2 adrenergic inhibitors, Weight reduction surgery history, Cardiovascular disease history, History of malignancy, Concomitant medications,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Portal Pressure",
          "HVPG measurement"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Liver biopsy results",
        "Platelet count",
        "Serum alanine aminotransferase levels",
        "Serum aspartate aminotransferase levels",
        "Serum albumin",
        "International normalized ratio (INR)",
        "Direct bilirubin",
        "Alpha fetoprotein",
        "Model End-Stage Liver Disease (MELD) score",
        "Child Turcotte Pugh Class",
        "Estimated creatinine clearance",
        "History of hepatic decompensation",
        "Presence of varices",
        "History of liver disease",
        "History of alcohol consumption",
        "History of solid organ transplant",
        "Use of nonselective \u03b2 adrenergic inhibitors",
        "Weight reduction surgery history",
        "Cardiovascular disease history",
        "History of malignancy",
        "Concomitant medications"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, HVPG, Ishak Stage, Liver Biopsy Results, Presence of Varices, Diabetes Status, History of Obesity, History of Hypertension, History of Cardiovascular Disease, History of Liver Disease, Laboratory Values (ALT, AST, Platelet Count, Albumin, INR, Bilirubin, AFP), MELD Score, Child-Turcotte-Pugh Class, Creatinine Clearance, History of Smoking, History of Alcohol Consumption.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Portal Pressure",
          "HVPG"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "BMI",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Ishak Stage",
        "Liver Biopsy Results",
        "Presence of Varices",
        "Diabetes Status",
        "History of Obesity",
        "History of Hypertension",
        "History of Cardiovascular Disease",
        "History of Liver Disease",
        "Laboratory Values (ALT, AST, Platelet Count, Albumin, INR, Bilirubin, AFP)",
        "MELD Score",
        "Child-Turcotte-Pugh Class",
        "Creatinine Clearance",
        "History of Smoking",
        "History of Alcohol Consumption"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), liver biopsy Ishak stage, HVPG measurement, presence of varices, history of obesity, history of diabetes mellitus, history of statin use, history of angiotensin converting enzyme inhibitor use, history of angiotensin II receptor blocker use, history of \u03b21 selective adrenergic receptor inhibitor use, serum alanine aminotransferase levels, serum aspartate aminotransferase levels, platelet count, serum albumin, international normalized ratio (INR), direct bilirubin, alpha fetoprotein, Model End-Stage Liver Disease (MELD) score, Child Turcotte Pugh Class.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Portal Pressure",
          "HVPG measurement"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "liver biopsy Ishak stage",
        "presence of varices",
        "history of obesity",
        "history of diabetes mellitus",
        "history of statin use",
        "history of angiotensin converting enzyme inhibitor use",
        "history of angiotensin II receptor blocker use",
        "history of \u03b21 selective adrenergic receptor inhibitor use",
        "serum alanine aminotransferase levels",
        "serum aspartate aminotransferase levels",
        "platelet count",
        "serum albumin",
        "international normalized ratio (INR)",
        "direct bilirubin",
        "alpha fetoprotein",
        "Model End-Stage Liver Disease (MELD) score",
        "Child Turcotte Pugh Class"
      ]
    }
  }
}